FANCG Antikörper

Produktnummer ABIN2423431

Produktdetails anti-FANCG Antikörper

Target: FANCG (Fanconi Anemia Complementation Group G (FANCG))

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser FANCG Antikörper ist unkonjugiert

Applikation: ELISA, Immunohistochemistry (IHC)

Aufreinigung: Affinity purification

Immunogen: Recombinant protein of human FANCG

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: IHC 1:50-1:200

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 1 mg/mL

Buffer: PBS with 0.05 % sodium azide and 50 % glycerol, PH7.4

Konservierungsmittel: Sodium azide

Handhabung: Avoid freeze / thaw cycles.

Lagerung: -20 °C

Informationen zur Lagerung: Store at -20°C. Avoid freeze / thaw cycles.

Details zu FANCG

Target: FANCG (Fanconi Anemia Complementation Group G (FANCG))

Andere Bezeichnung: FANCG (FANCG Produkte)

Synonyme: xFANCG antikoerper, FAG antikoerper, XRCC9 antikoerper, AU041407 antikoerper, Xrcc9 antikoerper, Fanconi anemia complementation group G S homeolog antikoerper, Fanconi anemia complementation group G antikoerper, Fanconi anemia, complementation group G antikoerper, fancg.S antikoerper, FANCG antikoerper, Fancg antikoerper

Hintergrund: The Fanconi anemia complementation group (FANC) currently includes FANCA, FANCB, FANCC, FANCD1 (also called BRCA2), FANCD2, FANCE, FANCF, FANCG, FANCI, FANCJ (also called BRIP1), FANCL, FANCM and FANCN (also called PALB2). The previously defined group FANCH is the same as FANCA. Fanconi anemia is a genetically heterogeneous recessive disorder characterized by cytogenetic instability, hypersensitivity to DNA crosslinking agents, increased chromosomal breakage, and defective DNA repair. The members of the Fanconi anemia complementation group do not share sequence similarity, they are related by their assembly into a common nuclear protein complex. This gene encodes the protein for complementation group G.

Pathways: DNA Reparatur